Feb 15 2019 |
FDA Publishes Findings from Investigation of Romaine Lettuce E. coli Outbreak |
Keller and Heckman LLP |
Feb 14 2019 |
Regulatory Developments EC Begins Public Consultation on Evaluation of FCMs |
Bergeson & Campbell, P.C. |
Feb 14 2019 |
FDA Takes Action on Dietary Supplements Claiming to Treat Alzheimer’s Disease and Other Serious Conditions |
Keller and Heckman LLP |
Feb 14 2019 |
Remote Prescribing Trends in Telehealth |
Epstein Becker & Green, P.C. |
Feb 14 2019 |
HIMMS19 Conference – Blockchain Symposium Recap |
Sheppard, Mullin, Richter & Hampton LLP |
Feb 13 2019 |
CBD “Edibles” Face Opposition from States, FDA |
Epstein Becker & Green, P.C. |
Feb 13 2019 |
JRC Publishes Overview of Concepts and Terms Used in the EC’s Definition of Nanomaterial |
Bergeson & Campbell, P.C. |
Feb 13 2019 |
DOJ Expands New Enforcement Tactic – Obtains TRO to Prevent Pharmacy From Dispensing Opioids |
McDermott Will & Schulte LLP |
Feb 13 2019 |
New York Judge Lifts 2-Year Stay on KIND “All Natural” Suit |
Keller and Heckman LLP |
Feb 12 2019 |
New York City Bans CBD from Bars and Restaurants |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Feb 12 2019 |
Update on Pending Legislation: Three New Bills Have the Potential to Affect Generic Pharmaceutical Companies |
Polsinelli PC |
Feb 12 2019 |
FDA Adds Three New Substances to its Inventory of Effective FCS Notifications |
Keller and Heckman LLP |
Feb 12 2019 |
FDA to Strengthen Dietary Supplements Regulation |
Keller and Heckman LLP |
Feb 11 2019 |
In Surprising Ruling, McDonald’s Loses BIG MAC Trademark Registration In The EU |
Barnes & Thornburg LLP |
Feb 11 2019 |
HHS Proposes Rule to Eliminate Safe Harbor for PBM Drug Rebates |
Sheppard, Mullin, Richter & Hampton LLP |
Feb 11 2019 |
E-cigarette Companies Raising Nicotine Levels to Compete with Juul |
Stark & Stark |
Feb 11 2019 |
45 States Now Have Biosimilar Substitution Laws |
Mintz |
Feb 11 2019 |
EU Publishes Updated Draft of Single-Use Plastics Directive |
Keller and Heckman LLP |
Feb 11 2019 |
Federal Circuit Dismisses Appeal of IPR Final Written Decision for Lack of Standing After Appellant Terminated Development of Potentially Infringing Pharmaceutical Product |
Mintz |
Feb 11 2019 |
State of California Passes Law Limiting Sugary Drinks Offered in Children’s Meals |
Greenberg Traurig, LLP |
Feb 11 2019 |
Finalized Guidance for Industry and FDA Staff on Public Warning and Notification of Firm-Initiated or FDA-Requested Recalls |
Keller and Heckman LLP |
Feb 11 2019 |
State of Nature: District Courts Diverge in Treatment of “Natural” False Advertising Claims |
Proskauer Rose LLP |
Feb 8 2019 |
E-Cigarettes Effective for Smoking Cessation, Study Finds |
Keller and Heckman LLP |
Feb 8 2019 |
Growth Energy Applauds Made-In-Ontario Environment Plan |
Bergeson & Campbell, P.C. |
Feb 8 2019 |
McDermott Plus Check-Up: February 8, 2019 |
McDermott Will & Schulte LLP |
Feb 8 2019 |
Genetic Testing Comes at a Cost |
Robinson & Cole LLP |
Feb 8 2019 |
FDA Takes Action Against Retailers Selling Tobacco Products to Minors |
Keller and Heckman LLP |
Feb 8 2019 |
How to Safely and Productively Promote an FDA-Regulated Medical Product |
Mintz |
Feb 7 2019 |
House Financial Services Committee to Consider Cannabis Banking Issues |
McDermott Will & Schulte LLP |
Feb 7 2019 |
FDA Issues Final Guidance On Least Burdensome Provisions For Medical Devices |
Barnes & Thornburg LLP |
Feb 7 2019 |
2018 Digital Health Year in Review: Focus on Care Coordination and Reimbursement |
McDermott Will & Schulte LLP |
Feb 7 2019 |
Proposed EU Hygiene Rules for Insects Used in Food |
Keller and Heckman LLP |
Feb 7 2019 |
E-Cigarette Explosion Kills Texas Man |
Stark & Stark |
Feb 7 2019 |
San Francisco City Ordinance Takes a Hard Hit in Ninth Circuit Soft Drink Lawsuit |
Proskauer Rose LLP |
Feb 6 2019 |
FDA Evaluation of GRAS Notices and FCNs Resumes |
Keller and Heckman LLP |